JAGX
Jaguar Health, Inc.
Going-concern doubt
— flagged May 20, 2026
Substantial doubt about the company's ability to continue as a going concern.
“These conditions, along with recurring operating losses and an accumulated deficit, raise substantial doubt about the Company’s ability to continue as a going concern for a period of one year from the issuance of these consolidated financial statements.”View the 10-Q filed May 20, 2026
Company with tickers: JAGX
Market Cap
$515.76M
Shares Outstanding
171,350,166
CIK
1585608
CUSIP
47010C888
Website
Visit website
Private capital raises reported to the SEC on Form D under Regulation D, showing the offering size, amount sold, minimum investment and number of investors. Public operating companies rarely raise capital this way, so this page is often empty.
| Filed | Type | Industry | Offering | Sold | Exemptions |
|---|---|---|---|---|---|
| 2025-11-24 | New | Pharmaceuticals | $10,810,000 | $10,810,000 | 06b |
| 2025-10-10 | New | Pharmaceuticals | $1,000,000 | $1,000,000 | 06b |
| 2025-09-23 | New | Pharmaceuticals | $2,377,000 | $2,377,000 | 06b |
| 2025-05-28 | New | Pharmaceuticals | $1,500,003 | $1,500,003 | 06b |
| 2023-11-30 | New | Pharmaceuticals | $60,000 | $60,000 | 06b |
| 2023-05-11 | New | Pharmaceuticals | $1,832,304 | $1,832,304 | 06b |
| 2023-05-11 | New | Pharmaceuticals | $1,857,453 | $1,857,453 | 06b |
| 2022-09-23 | New | Pharmaceuticals | $7,140 | $7,140 | 06b |
| 2022-09-02 | New | Pharmaceuticals | $12,000,000 | $12,000,000 | 06b |
| 2022-07-08 | New | Pharmaceuticals | $10,000,000 | $300,000 | 06b |
| 2022-04-26 | New | Pharmaceuticals | $50,820 | $50,820 | 06b |
| 2022-04-25 | New | Pharmaceuticals | $39,800 | $39,800 | 06b |
| 2022-04-25 | New | Pharmaceuticals | $7,572 | $7,572 | 06b |
| 2021-09-24 | New | Pharmaceuticals | $776,197 | $776,197 | 06b |
| 2021-03-26 | New | Pharmaceuticals | $10,000,000 | $10,000,000 | 06b |
| 2021-02-04 | New | Pharmaceuticals | $6,220,812 | $6,220,812 | 06b |
| 2021-02-04 | New | Pharmaceuticals | $12,000,000 | $12,000,000 | 06b |
| 2020-09-17 | New | Pharmaceuticals | $1,087,500 | $1,087,500 | 06b |
| 2020-06-05 | New | Pharmaceuticals | $4,447,779 | $4,447,779 | 06b |
| 2020-04-08 | New | Pharmaceuticals | $720,000 | $720,000 | 06b |
| 2020-04-07 | New | Pharmaceuticals | $2,030,000 | $2,030,000 | 06b |
| 2020-01-06 | New | Pharmaceuticals | $1,500,000 | $1,500,000 | 06b |
Showing 1–22 of 22 filings